
Keros is a biopharmaceutical company focused on treatments for rare muscle diseases. Its lead program is a small molecule for the treatment of FOP, an ultra-rare skeletal disease.
biopharmaceuticals
Public (NYSE:KROS)
Visit Website
https://www.kerostx.com/
Additional Portfolio Companies